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Abstract
Background: The effects of putative risk factors on the onset and/or persistence of depression
remain unclear. We aim to develop comprehensive models to predict the onset and persistence of
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episodes of depression in primary care. Here we explain the general methodology of the predictD-
Spain study and evaluate the reliability of the questionnaires used.
Methods: This is a prospective cohort study. A systematic random sample of general practice
attendees aged 18 to 75 has been recruited in seven Spanish provinces. Depression is being
measured with the CIDI at baseline, and at 6, 12, 24 and 36 months. A set of individual,
environmental, genetic, professional and organizational risk factors are to be assessed at each
follow-up point. In a separate reliability study, a proportional random sample of 401 participants
completed the test-retest (251 researcher-administered and 150 self-administered) between
October 2005 and February 2006. We have also checked 118,398 items for data entry from a
random sample of 480 patients stratified by province.
Results:  All items and questionnaires had good test-retest reliability for both methods of
administration, except for the use of recreational drugs over the previous six months. Cronbach's
alphas were good and their factorial analyses coherent for the three scales evaluated (social
support from family and friends, dissatisfaction with paid work, and dissatisfaction with unpaid
work). There were 191 (0.16%) data entry errors.
Conclusion: The items and questionnaires were reliable and data quality control was excellent.
When we eventually obtain our risk index for the onset and persistence of depression, we will be
able to determine the individual risk of each patient evaluated in primary health care.
Background
Depression as a public health problem
In 2001 depression was the third leading cause of disease
burden in high-income countries [1]. In 2004 the total
annual cost of depression in Europe was estimated to be
118 billion euros, or 253 euros per inhabitant [2]. The
prevalence of major depression is about 7% in the com-
munity [3] and 14% in general practice attendees [4].
Relapse is frequent up to 10 years after the first presenta-
tion [5] and residual disability is common [6].
Risk factors for depression
The prevalence of depression is determined by exposure
to risk factors that precipitate or maintain episodes of
depression. With few exceptions, the prevalence and inci-
dence of depressive disorders are higher in females than
males, beginning at mid-puberty and persisting through
adult life, although the determinants of gender differences
are far from being established [7]. Socio-economic risk
factors that might conceivably be addressed include low
income and financial strain [8], unemployment [9], work
stress [10], social isolation [11] and poor housing [12].
Relative poverty and unemployment are associated with a
longer duration of episodes of depression rather than
their onset [8], and depressive symptoms are also associ-
ated with subsequent unemployment and loss of family
income [13]. Fixed factors such as a family history of
depression [14] and personality [15] play a part but it is
uncertain whether they act independently of other risk
factors [16]. Physical health has been related to the onset
and persistence of depression [17]. Stressful life events
pose a greater risk for depression among women com-
pared to men [18] and, like social support [19], these
events also seem to be both a cause and a consequence of
depression [20]. Many other candidate risk factors for
depression exist, including for example childhood social
disadvantage [21], childhood maltreatment [22], cigarette
smoking [23], alcohol and drug abuse [24], and anxiety
disorders [25].
However, the study of risk factors for depression suffers
from limitations: First, it is often difficult to distinguish
between their effects on the onset and on the course of
depression; second, several risk factors may interact and
be either a cause or a consequence of depression; and
finally, few studies have controlled for candidate risk fac-
tors with comprehensive models, possibly due to the
many possible factors involved.
Depression risk indexes
Effective strategies for preventing depression and reducing
disease burden are hindered by a dearth of evidence about
whether the risk for major depression can be quantified in
the same way as other clinical disorders, such as cardio-
vascular diseases [26].
The predictD study is a pioneering international study
whose main objective was to develop a risk index for the
onset of episodes of major depression in general practice
attendees [26]. The predictD international study recruited
and followed-up a large sample of general practice attend-
ees over one year. From 39 potential risk factors for
depression, a risk index of 10 risk factors was drawn up
with an excellent predictive power and good external
validity [27].BMC Public Health 2008, 8:256 http://www.biomedcentral.com/1471-2458/8/256
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The predictD-Spain study
Drawing on our experience as part of the predictD inter-
national study [28], the predictD-Spain study aimed to
improve certain methodological aspects, extending the
follow-up for three years, considering genetic factors in
the equation (the predictD-Gene study), and studying
professional and organizational factors as contributors to
both the onset and persistence of episodes of depression
(the predictD-Services study).
A genetic predisposition to depression may be a potential
risk factor in the development of depression. Although
the neurobiological equivalent of the predisposition
remains unclear, the brain's serotonin system appears to
play an important mediating role. Individuals with the 5-
HTTLPR s/s genotype are more prone to develop depres-
sion [29], and this genotype may determine stress coping
mechanisms and thereby increase stress vulnerability
[30].
A recent systematic review identified only 17 longitudinal
studies of depression in primary care, most of which
involved small sample sizes or were relatively short-term
[31]. The most usual risk factors for persistence of depres-
sion in primary care were severity and chronicity of the
depressive episode, the presence of suicidal thoughts,
poorer self-reported quality of life, lower self-reported
social support, experiencing key life events, antidepres-
sant use, lower education level and unemployment. How-
ever, whether differences exist in depression outcomes
between patients whose depressive disorders are recog-
nized and those whose disorders are unrecognised in pri-
mary health care is unclear [32].
In Spain, general practitioneers (GPs) failed to detect 30%
of depressed patients [33], while only 30% of those diag-
nosed received appropiate treatment [34]. The suitable
use of antidepressants, medication adherence, and 'case
management' between mental health specialists and pri-
mary care professionals might be some of the best predic-
tors for the recovery from depression [35]. Thus, the need
to control for these factors in predictive models on the
persistence of depression in primary care is clear [36].
Each anxiety disorder and panic attack appears to confer
an independent risk for the onset of major depression
[25] and an association between psychopharmacological
treatment for generalized anxiety disorders and a lower
risk of depression has been suggested [37]. However, anx-
iety disorders are not always adequately detected and
managed by GPs [38]. Consequently, the detection and
treatment of anxiety disorders might also condition the
onset of depression.
Several GP factors are related with their ability to detect
and manage psychosocial problems: gender, interview
training, previous doctor-patient relationship or psycho-
social orientation [39-42]. Concerning organizational fac-
tors, a recent meta-analysis showed that collaborative care
for depression improved the outcome [43]. The most
commonly used intervention features in the collaborative
care were patient education and self-management, moni-
toring of depressive symptoms and treatment adherence,
decision support for medication management, a patient
registry, and mental health supervision of care managers
[44]. Finally, one of the best professional-organizational
factors associated with the recognition and good manage-
ment of psychosocial problems in primary care is the
length of interviews [42,45].
Accordingly, we aim to develop comprehensive models to
predict the onset and persistence of episodes of depres-
sion in primary care. As well as individual, genetic, and
environtmental risk factors, we are also considering other
professional and organizational factors. In this report we
explain the general methodology of the study and evalu-
ate the reliability of the questionnaires used.
Methods/Design
Design
This prospective cohort study has recruited a systematic
random sample of general practice attendees to be fol-
lowed up after 6, 12, 24 and 36 months. The prevalence of
depression and risk factors for depression are to be
assessed at baseline and at each follow-up point. After
excluding the patients with depression at baseline, the
incidence of depression is to be measured at 6, 12, 24 and
36 months. This project is in compliance with the Hel-
sinki Declaration and the relevant ethics committees in
each province have approved the study. In representation
of them, from the coordinator centre, the "Comité de Ética
e Investigación Sanitaria del Distrito Sanitario de Atención
Primaria de Málaga" approved the study.
Setting
Seven provinces are participating with 41 health centres
and 231 GPs distributed throughout Spain: Malaga and
Granada in southern Spain; Zaragoza and La Rioja in
northern Spain; Madrid, capital of Spain, situated in the
centre; Las Palmas in the Canary Islands; and Majorca in
the Balearic Islands. Each health centre, which covers a
population of 15,000 to 30,000 inhabitants from a geo-
graphically defined area, is staffed by GPs, who see
patients over the age of 14 years, and by primary care pae-
diatricians. The GPs in each health centre work as a group,
with extensive primary care teams. The Spanish National
Health Service provides free medical cover to 100% of the
population. The health centres taking part extend over
urban and rural settings in each province.BMC Public Health 2008, 8:256 http://www.biomedcentral.com/1471-2458/8/256
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Sample and exclusion criteria
A systematic random sample taken at regular intervals of
between 4 and 6 attendees, aged 18 to 75, has been
recruited in six Spanish provinces. The 7th  province,
Malaga, started between October 2003 and February 2004
because it was already participating in the predictD inter-
national study [26]. The GPs introduce the study to the
selected patients and request permission before contact-
ing the assistant researcher. Patients over 75 years of age
have been excluded because the prevalence of cognitive
impairment increases after that age. Other exclusion crite-
ria include inability to speak or understand Spanish (for-
eigners), severe organic mental disease and terminal
illness, patients due to be away for more than 3 months
during the coming year, and persons (representatives)
who attend the surgery on behalf of the person who has
the appointment (for example, to collect a prescription or
a certificate). Participants who have given informed con-
sent have an interview at the health centre within two
weeks. The sample size was computed, using Obuchowski
expression [46], to estimate the area under the ROC curve
of the index to be obtained. Assuming an area under the
ROC curve of 0.80 and a precision of 0.06, and consider-
ing an intraclass correlation coefficient of 0.05 with an
average of 11 patients per GP in the cluster, the sample
size needed was 3,474 patients for an incidence of major
depression of about 12% per year.
Outcome measures
Our outcome variable is a depressive disorder. Depression
is measured with the 12-month (or modified to 6-month)
Depression Section of the Composite International Diag-
nostic Interview (CIDI) [47-49], which provides psychiat-
ric diagnoses according to ICD10 and DSM-IV.
Risk factors for depression
The selection of risk factors for the onset and persistence
of depression was designed to cover all important areas
identified in a systematic review of the literature, consid-
ering specially those assessed in the predictD interna-
tional study [26], in addition to other possible
professional and organizational risk factors. Where possi-
ble, we used published measures with established reliabil-
ity and international validity, including in Spain. Where
this was not possible we translated the measures into
Spanish. Each translation was back-translated by profes-
sional translators. In some cases, questions were devel-
oped for the study or adapted from available standardised
instruments. These questions were evaluated for test-retest
reliability. Scales without validation data in Spain were
also evaluated on their internal consistency and factorial
validity.
Individual and environmental risk factors
￿ Socio-demographic factors: age, marital status, occupa-
tion, employment status, ethnicity, nationality, country of
birth, educational level, income, owner occupier accom-
modation, living alone or with others.
￿ Controls, demands and rewards for unpaid and paid
work, using an adapted version of the job content instru-
ment [50].
￿ Debt and financial strain [9].
￿ Consultation rate in the general practice through com-
puterized clinical notes [51].
￿ Physical and mental well-being, assessed by the SF-12
that has application across a number of cultures [52],
including Spain [53]; and a question on the presence of
long-standing illness, disability or infirmity.
￿ Alcohol abuse using the WHO AUDIT questionnaire
[54], the Spanish validation of which slightly modified
the threshold for female hazardous drinkers [55,56].
￿ Use of recreational drugs (at least once in the past and
over the previous six months) adapted from the relevant
sections of the CIDI.
￿ A life-time screen for depression based on the first two
questions of the CIDI. People answering yes to both ques-
tions screened positive [57].
￿ Brief questions on cigarette consumption.
￿ For women, questions on menstruation, pregnancy and
childbirth from the Patient Health Questionnaire (PHQ)
[58].
￿ Brief questions on the quality of sexual and emotional
relationships with a partner, adapted from a standardized
questionnaire [59].
￿ Presence of serious physical, psychological or substance
misuse problems, or any serious disability, in persons
who are close friends or relations of participants; and dif-
ficulty getting on with people and maintaining close rela-
tionships, assessed using questions from a social
functioning scale [60].
￿ Childhood experiences of physical, emotional or sexual
abuse [61].
￿ Nature and strength of spiritual beliefs [62].BMC Public Health 2008, 8:256 http://www.biomedcentral.com/1471-2458/8/256
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￿ Family psychiatric history in first-degree family mem-
bers requiring pharmacological or psychological treat-
ment in primary or secondary care, and suicide in first-
degree relatives [63].
￿ Anxiety symptoms using the anxiety section of the
PRIME-MD [58]. The Spanish version provides psychiatric
diagnoses according to DSM-IV: Panic Attack, Generalised
Anxiety Disorder and Other Anxiety Disorders [64].
￿ One question on whether and when (at what age) the
participant had lost one or both parents by death.
￿ Household type and composition.
￿ The living environment, including satisfaction with
neighbourhood and perception of safety inside/outside
the home using questions from the Health Surveys for
England [65].
￿ Recent life-threatening events, using a brief validated
checklist [66].
￿ Experience of discrimination on the grounds of sex, age,
ethnicity, appearance, disability or sexual orientation
using questions from a recent European study [67].
￿ Adequacy, availability and sources of social support
from family and friends [68].
Genetic risk factors
The participants give their general informed consent and
are asked for a new and specific informed consent on
genetic tests. We collect saliva and/or blood for genetic
testing, with DNA from both blood and saliva obtained
by standard procedures. The 5-HTTLPR polymorphism at
SLC6A4 is to be genotyped in all samples, as described
[29,30].
Professional and organizational risk factors
This group of variables will be gathered from computer-
ised clinical notes, centralised administrative records, and
a brief questionnaire to the GPs at 12, 24 and 36 months.
￿ GP characteristics: age, gender, year of degree in Medi-
cine, postgraduate training and speciality, type of con-
tract, time in the current health centre, list size, mean time
per patient during the previous year, satisfaction with rela-
tionships and collaborative care between GP and mental
health team, social worker, and nurse practitioner, self-
perceived comfort with antidepressant use, and a ques-
tionnaire on professional satisfaction, perception of work-
load, and psychosocial orientation [69].
￿ Health Centre characteristics: size of population
attended, number of inhabitants in the city or town, pre-
dominant activity in the city or town (agriculture-fishing,
industry or services), number and type of professionals in
the team, professional-population ratios, type and inten-
sity of relationship with Mental Health team (case man-
agement, patient care and shared continued medical
education), and "centred variables" (mean or median of
the GP characteristics in each health centre).
￿ Interaction professional-organization-patient variables:
number of visits to health centre team, i.e., GP, nurse, and
social worker; referrals to the Mental Health team by GPs
or direct approaches to mental health specialists by the
patient privately; patient's psychosocial and physical
problems detected by their GPs; and antidepressants, ben-
zodiazepines or other psychological drugs prescribed
(type, dose and duration).
Data checking
Locally, each interview is checked for completion by the
interviewer. Quality assurance is focused on the standard-
ised training of researchers in the use of the CIDI and
other questionnaires, on the recruitment and interviewing
of patients and on data management. Over and above
team meetings at the provincial level, a research coordina-
tor assesses each interviewer twice during recruitment to
monitor the interview process, verifies adherence to the
CIDI and manages other problems as they arise. Progress
reports for each province are submitted every two months
and examined critically by the steering group at project
management meetings. Each participating province dou-
ble-enters 10% of its data records and a 1% error rate is
accepted.
Statistical analysis
When all follow-ups are complete we shall be able to
identify risk factors for the incidence (from participants
not depressed at baseline) and recovery-persistence (from
depressed participants) of depression over 6, 12, 24 and
36 months. The occurrence of major depression (yes/no)
will be the dependent variable of multiple logistic regres-
sions from a multilevel analysis that will discern three lev-
els: patient, GP and health centre. The province will be
included as a fixed factor since only seven units are
involved. When we consider repeated measurements from
different times of the follow-up, multilevel analysis will
include four levels: time, patient, GP and health centre. A
hierarchical model will be used to take into account the
distribution of the data at different levels to estimate two
types of variability, one due to individuals in the study
and another due to the groups in which patients are
nested. The candidate risk factors in each level will be
included in the model using an entrance value of P < 0.10.
For each level, the usefulness of including first-degreeBMC Public Health 2008, 8:256 http://www.biomedcentral.com/1471-2458/8/256
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interactions in the equation will be considered, and the
interactions between levels will also be studied.
Missing data for candidate risk factors will be imputed
using multiple imputation by chained equations (MICE),
in which each variable is imputed using a regression
model conditional on all the others, iteratively cycling
through all the variables that contain missing data [70].
We will conduct the analysis in each of 10 imputed data-
sets and will obtain combined estimates; 10 imputed data
sets is a common choice by convention [71]. We will
repeat the analysis in just those participants with com-
plete information as a sensitivity analysis. These analyses
will be performed by the STATA "ice" command [72].
We will calculate the c-index [73] to estimate the discrim-
inative power of the final model at each time. We will use
a calculation proposed by Copas [74] to adjust for over-
fitting of our prediction models. We will assess the good-
ness of fit of the final risk model by grouping individuals
into deciles of risk and comparing the observed probabil-
ity of major depression within these groups with the aver-
age risk. We will calculate effect sizes using Hedge's g [75]
for the difference in log odds of predicted probability
between patients who will later be observed to be
depressed and those who will not be depressed. All these
analyses will be run with STATA release 10.
We have calculated test-retest agreement using the Kappa
statistic, which adjusts for chance agreement, for ques-
tions with two response options and the Intraclass Corre-
lation Coefficient (ICC) for items with more than two
[76]. We have evaluated the internal consistency of the
scales through Cronbach's alpha, and explored their sub-
jacent factors through factorial analysis by principal com-
ponents and varimax rotation. Reliability and validity
analyses have been run with SPSS 14.
Results
Reliability
For the test-retest analysis, we selected a random sample
of 401 patients stratified by province; 251 completed the
predictD-Spain questionnaires as researcher-administered
and 150 as self-administered questionnaires between
October 2005 and February 2006. The respective distribu-
tion by province was: Madrid 41/39, Granada 40/38, La
Rioja 49/24, Las Palmas 42/20, Malaga 41/0, Majorca 28/
19, and Zaragoza 10/10. The mean number of days
between test and retest was 11.0 (95% CI, 10.2–11.8;
standard deviation = 7.5).
Additional file 1 shows reliability coefficients for all items
and questionnaires evaluated. Most of the coefficients
were good or excellent. Use of recreational drugs over the
previous six months had poor agreement for the two
methods of questionnaire administration. One item on
the perception of safety inside the home had a coefficient
of 0.80 (excellent) for researcher-administered and 0.37
(poor) for self-administered questionnaires, and another
on cigarette consumption also had poor agreement
(researcher-administered = 0.85 and self-administered =
0.40), although only for the self-administered way.
We evaluated the internal consistency of three scales: dis-
satisfaction with unpaid work, dissatisfaction with paid
work and social support from family and friends. The
respective Cronbach's alphas were good (Additional file
1).
Validity
Factorial analysis of the scale dealing with social support
from family and friends found one factor that explained
58.7% of the variance. Factorial analysis of the scale deal-
ing with dissatisfaction with paid work found three factors
that explained 81.6% of the variance: F1 "feeling in con-
trol" (3 items = 28.3%), F2 "experiencing difficulty with-
out support" (2 items = 26.4%), and F3 "experiencing
distress without being respected" (2 items = 26.9%). Fac-
torial analysis of the scale dealing with dissatisfaction
with unpaid work differed slightly from the scale dealing
with paid work. It found two factors that explained 77.3%
of the variance: F1 "feeling in control without difficulties
and with gratitude" (5 items = 50.4%) and F2 "experienc-
ing distress without support and being respected" (2 items
= 26.9%).
Error rates for data entry
The baseline error rates for data entry in each province are
well below the 1% level of acceptability. We have checked
118,398 items from a random sample of 480 patients
stratified by province and found only 191 errors (0.16%).
Discussion
The questionnaires used showed good reliability and the
factorial validity of the three scales tested was coherent.
Quality control of data was excellent.
Reliability and validity analysis
The results of reliability analyses were good or excellent
for practically all the questionnaires and items. This sug-
gests that data stability over time is satisfactory. We were
interested in testing the questionnaires using both meth-
ods of administration, researcher-administered and self-
administered, since, for cultural reasons; questionnaires
administered to primary care attendees in Spain are
almost always researcher-administered. Moreover, we also
wanted to test whether self-administered questionnaires
have different degrees of reliability as a result of a different
socio-cultural patient profile (higher level of education,
income and social class), the variability introduced byBMC Public Health 2008, 8:256 http://www.biomedcentral.com/1471-2458/8/256
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interviewers, or other circumstances. In the end, the test-
retest reliability was similar for most items with both
methods of administration, although we did not measure
inter-interviewer reliability. Nevertheless, several differ-
ences were interesting. The perception of safety inside the
home had an excellent coefficient for researcher-adminis-
tered questionnaires and a poor coefficient for self-admin-
istered questionnaires. Perhaps not all the patients
interpreted this question the same way or maybe some
were less sincere. We think that it was probably a "hot"
question, perhaps interpreted as domestic violence, and,
when the interviewers were not directly present; the
patient may have felt less need to be sincere. It might also
be that the question was a bit ambiguous. Fewer doubts
concerned the absence of reliability for the item on the use
of any recreational drugs over the previous 6 months. It
contrasted with the good reliability of the same question
in reference to the use of recreational drugs at least once.
From the viewpoint of social desirability it is coherent, as
it is considered better to try a drug than to consume it
more often. A similar reasoning could be attributed to the
item on cigarette consumption per day, although it is only
a hypothesis. However, the predictD-International study
obtained good coefficients for both time references on
drug consumption [26]. In any case, we have decided not
to include the use of recreational drugs over the previous
six months in the final analysis of risk factors. The items
on perception of safety inside the home and consumption
of cigarettes per day will also be excluded from the final
analyses.
Factorial analysis and Cronbach's alpha of the scale deal-
ing with support from family and friends showed that its
use as a single scale is appropriate. This is a conceptual dif-
ference with those questionnaires that separate support
from family and support from friends [77]. The 7 items
that we used on dissatisfaction with paid and dissatisfac-
tion with unpaid work were adapted from the "Job Con-
tent Questionnaire" (JCQ), based on Karasek's demand-
control-support model [78]. Our factorial analysis of paid
work identified three factors that coincide with those
obtained by the JCQ in different countries (job control,
social support and psychological demands). However,
factorial analysis of unpaid work changed. This was to be
expected, as most unpaid work was probably related with
looking after the family or the home, though we are una-
ware of any background to this question in the literature.
Whatever the case, both Cronbach's alphas justified the
use of each scale as a single scale.
Significance and practical implications of the study
These comprehensive models for the prediction of depres-
sion will facilitate the understanding of its causes, specify-
ing the contribution of each risk factor and the
importance of patient, environmental, genetic, profes-
sional and organizational factors. When we eventually
obtain our risk index for the onset of depression, we will
be able to determine the individual risk of each patient
evaluated in primary health care. We hope to produce a
simple prediction tool similar to the cardiovascular risk
index [79]. Additionally, we plan to develop another risk
index for recovery from depression, thus laying the foun-
dation for future research on risk reduction in primary
care.
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